Impact of Lumateperone compared to Quetiapine on Quality of Life of Indian patients with Bipolar II depression: A post-hoc analysis of a Phase 3 study

A. Dharmadhikari(Shree Krishna Hospital), Sahil Mehta(Sun Pharma (Japan)), Sujit Sarkhel(Institute of Neurosciences Kolkata), Dipak D. Patil(Sun Pharma (Japan)), Yash Patel(Ahmedabad Civil Hospital), G. Ganesan(MediHope Super Specialty Hospital), Moumita Dutta(Omuta hospital), P. S. Meena(Jawaharlal Nehru Medical College), Kamila B. Mistry(National Institute of Occupational Health), Devendra Kumar Choudhary(Ganesh Shankar Vidyarthi Memorial Medical College), G. T. Harsha(Rajarajeswari Medical College and Hospital), Anupama Mane(Sun Pharma (Japan)), N.V.V. Jyothi(Sri Venkateswara University), P. K. Chaurasia(Mahatma Gandhi Kashi Vidyapith), M. Bhirud(Dhulikhel Hospital), N. K. Sooch(Dayanand Medical College & Hospital), P. H. Devkare(Sun Pharma (Japan)), Giridhar U. Kulkarni(Jawaharlal Nehru Centre for Advanced Scientific Research), Aditya Kumar(Sarojini Naidu Medical College), Anil N. Shetty(Sun Pharma (Japan)), Sanjay Goyal(Her Majesty's Revenue and Customs), Sohini Dey(Indian Veterinary Research Institute), Amal K. Mukhopadhyay(Nil Ratan Sircar Medical College and Hospital), Mousam Parikh(B.J. Medical College), Poras Chaudhary, Sameer Belvi Mangalwedhe(Karnataka Institute of Medical Sciences), P. Ghadge(Sun Pharma (Japan)), A. Ramaraju(Unknown), B. P. S. Rathour(Institute of Child and Mother Health), Sarama Saha(Sun Pharma (Japan)), P. L. Dasud(Global Vaccines (United States)), Faraaz Shah(Ahmedabad Civil Hospital)

European Psychiatry

April 1, 2025

Cited by 0

|Indian Journal of Psychiatry|2020|361

|Veterinary Medicine Research and Reports|2019|108

|2018 International Conference on Current Trends towards Converging Technologies (ICCTCT)|2018|97

|Veterinary World|2018|91

|Veterinary Microbiology|2004|90

Related Papers